Montreal-based PACS firm Intelerad Medical Systems has received a "significant investment" from Canadian private equity firm Novacap.
The transaction is being financed through the Novacap TMT IV Fund, which specializes in partnering with companies that have growth potential in the technology, media, and telecommunications sectors, according to Intelerad.
The investment is intended to enhance Intelerad's operations, strategic growth opportunities, and funding of research and development programs.